Actuate Therapeutics Stock Forecast

ACTU's stock price has decreased by -83.45% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 4 analysts polled by S&P Global, Actuate Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $10.01. The average 1-year stock price forecast is 688.19% higher than the current stock price, while the lowest is $5.00 (+293.70%) and the highest is $15.05 (+1,085.04%).

Price Target: $10.01 (+688.19%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$5.00	$10.01	$10	$15.05
Change	+293.70%	+688.19%	+687.40%	+1085.0%

Analyst Ratings

The average analyst rating for Actuate Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Jan '26	Mar '26	Apr '26	May '26	Jun '26	Aug '26
Strong Buy	4	4	4	4	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Buy Maintains $15	Buy	Maintains	$15	+1,081.10%	Aug 18, 2026
Michael King Rodman & Renshaw	Rodman & Renshaw	Buy Initiates $6	Buy	Initiates	$6	+372.44%	Jul 30, 2026
Christopher Liu Lucid Capital	Lucid Capital	Buy Maintains $6 → $5	Buy	Maintains	$6 → $5	+293.70%	May 18, 2026
Albert Lowe Craig-Hallum	Craig-Hallum	Buy Maintains $12	Buy	Maintains	$12	+844.88%	May 12, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.72

from -1.06

EPS Next Year

-0.78

from -0.72

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-
Operating Income	-20.21M	-24.97M	-25.16M	-22.50M	-22.81M
EPS	-	-	-	-1.06	-0.72
Free Cash Flow	-	-12.64M	-12.39M	-11.04M	-21.00M
No. Analysts	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.72
Avg	-0.72
Low	-0.72

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-